Showing results (141-150 of 228) with videos related to
Sort By:
Pageof 23
Endocrine|April 13, 2015
Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort studyYoshitaka Hashimoto, Muhei Tanaka, Toshihiro Kimura, et al.Nutrients|December 31, 2025
Prediction of Postprandial Blood Glucose Variability Using Machine Learning in Frequent Insulin Injection Therapy with a Simplified Carbohydrate Counting ModelHiroyuki Tominaga, Masahide Hamaguchi, Youji Hamaguchi, et al.Diabetes, Obesity & Metabolism|April 22, 2026
Bifidobacteriuradm bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study)Genki Kobayashi, Yoshitaka Hashimoto, Tomoyuki Matsuyama, et al.Cells|April 30, 2026
Correction: Kobayashi et al. Pathogenesis of Graves' Disease Determined Using Single-Cell Sequencing with Thyroid Autoantigen Peptide Stimulation in B Cells. Cells 2025, 14, 1102Genki Kobayashi, Takuro Okamura, Yoshitaka Hashimoto, et al.Journal of Diabetes Investigation|October 1, 2020
Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA-HBP studyAya Kitae, Emi Ushigome, Yoshitaka Hashimoto, et al.Journal of Clinical Biochemistry and Nutrition|June 12, 2020
Reduced dietary omega-3 fatty acids intake is associated with sarcopenia in elderly patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort studyTakuro Okamura, Yoshitaka Hashimoto, Akane Miki, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|May 5, 2020
Immune modulating effects of additional supplementation of estradiol combined with testosterone in murine testosterone-deficient NAFLD modelTakuro Okamura, Masahide Hamaguchi, Ryo Bamba, et al.International Journal of Environmental Research and Public Health|July 2, 2021
Randomized Controlled Trial of Simple Salt Reduction Instructions by Physician for Patients with Type 2 Diabetes Consuming Excessive SaltChikako Oyabu, Emi Ushigome, Yuriko Ono, et al.Clinical Medicine Insights. Endocrinology and Diabetes|October 4, 2021
Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR TrialMasahide Hamaguchi, Yoshitaka Hashimoto, Toru Tanaka, et al.Nutrients|May 27, 2023
Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 DiabetesHanako Nakajima, Hiroshi Okada, Ayaka Kobayashi, et al.Pageof 23